logo
The US hasn't seen a human bird flu case in 3 months. Experts are wondering why

The US hasn't seen a human bird flu case in 3 months. Experts are wondering why

CNN20-05-2025

Health officials are making a renewed call for vigilance against bird flu, but some experts are puzzling over why reports of new human cases have stopped.
Has the search for cases been weakened by government cuts? Are immigrant farm workers, who have accounted for many of the U.S. cases, more afraid to come forward for testing amid the Trump administration's deportation push? Is it just a natural ebb in infections?
'We just don't know why there haven't been cases,' said Jennifer Nuzzo, director of the Pandemic Center at Brown University. 'I think we should assume there are infections that are occurring in farmworkers that just aren't being detected.'
The H5N1 bird flu has been spreading widely among wild birds, poultry and other animals around the world for several years, and starting early last year became a problem in people and cows in the U.S.
In the last 14 months, infections have been reported in 70 people in the U.S. — most of them workers on dairy and poultry farms. One person died, but most of the infected people had mild illnesses.
The most recent infections confirmed by the Centers for Disease Control and Prevention were in early February in Nevada, Ohio and Wyoming.
California had been a hotspot, with three-quarters of the nation's infections in dairy cattle. But testing and cases among people have fallen off. At least 50 people were tested each month in late 2024, but just three people were tested in March, one in April and none in May so far, state records show. Overall, the state has confirmed H5N1 infections in 38 people, none after Jan. 14.
During a call with U.S. doctors this month, one CDC official noted that there is a seasonality to bird flu: Cases peak in the fall and early winter, possibly due to the migration patterns of wild birds that are primary spreaders of the virus.
That could mean the U.S. is experiencing a natural — maybe temporary — decline in cases.
It's unlikely that a severe human infection, requiring hospitalization, would go unnoticed, said Michael Osterholm, a University of Minnesota expert on infectious diseases.
What's more, a patchwork system that monitors viruses in sewage and wastewater has suggested limited activity recently.
New infections are still being detected in birds and cattle, but not as frequently as several months ago.
'Given the fact that the number of animal detections has fallen according to USDA data, it's not surprising that human cases have declined as well,' the CDC said in a statement.
Dr. Gregory Gray said he wasn't concerned about the CDC not identifying new cases in months.
'I don't think that anybody's hiding anything,' said Gray, an infectious disease speicialist at the University of Texas Medical Branch in Galveston.
But Osterholm and some other experts think it's likely that at least some milder infections are going undetected. And they worry that the effort to find them has been eroding.
Resignations at the U.S. Department of Agriculture and the Food and Drug Administration's Center for Veterinary Medicine could slow the government's bird flu monitoring, said Keith Poulsen, director of the Wisconsin Veterinary Diagnostic Laboratory.
Three of 14 experts accepted deferred resignation offers at the National Animal Health Laboratory Network, which responds to disease outbreaks with crucial diagnostic information, he said. They are among more than 15,000 USDA staff to accept the offers, an agency spokesperson said.
And dozens of staff were fired at the FDA's Veterinary Laboratory Investigation and Response Network, which investigates animal diseases caused by problems including contaminated pet food. Cats in several states have been sickened and died after eating raw pet food found to contain poultry infected with H5N1.
Angela Rasmussen, a virologist at the University of Saskatchewan in Canada, said 'targeted surveillance has really dropped off precipitously since Trump took office.'
She wonders if immigrant farmworkers are too scared to come forward.
'I can't argue with anyone who would be risking getting shipped to a Salvadoran gulag for reporting an exposure or seeking testing,' she said.
The CDC characterizes the risk to the general public as low, although it is higher for people who work with cattle and poultry or who are in contact with wild birds.
Earlier this month, an agency assessment said there is a 'moderate risk' that currently circulating strains of bird flu could cause a future pandemic, but the CDC stressed that other emerging forms of bird flu has been similarly labeled in the past.
Still, research is continuing.
Texas A&M University scientists have collected blood samples from dairy workers in multiple states to test for signs of past H5N1 exposure, said David Douphrate, a workplace health and safety expert leading the project. The yearlong study is funded by a nearly $4 million grant from the CDC and is expected to conclude in July.
Douphrate said he leveraged two decades of relationships with dairy producers and workers to gain access to the farms.
'We have had very good participation,' Douphrate said. 'They have been very willing.'
Similar surveillance is 'urgently needed' among domestic cats, said Kristen Coleman, a researcher at the University of Maryland at College Park who studies emerging animal diseases. She recently released a paper reviewing bird flu in infections in cats between 2004 and 2024.
Barn cats that died after drinking raw milk were one of the first signs that dairy cows were becoming infected with bird flu in 2024. Since then, the Agriculture Department has confirmed more than 120 domestic cats infected with the virus across the U.S.
Infections have mostly been found in cats that died. Less is known about milder infections, whether cats can recover from bird flu — or whether the virus can spill over into people.
Coleman has been collecting blood samples from cats across the U.S. to see if they have evidence of previous exposure to the virus. But the process is slow and research funding is uncertain.
'It's easy to downplay something because that's usually what humans do,' she said. 'But what we really need to be doing is ramping up.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CDC backtracks on layoffs, rehires more than 400 people
CDC backtracks on layoffs, rehires more than 400 people

Yahoo

time29 minutes ago

  • Yahoo

CDC backtracks on layoffs, rehires more than 400 people

The Centers for Disease Control and Prevention is reinstating more than 400 people who had received layoff notices, according to an email from CDC leadership to employees seen by POLITICO. The rehiring, announced internally today, marks the largest number of employees that the agency has asked back to date. Around half of those employees are in the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention, and around a third are in the National Center for Environmental Health. Other divisions seeing reinstatements include the National Center for Health Statistics, Center for Forecasting and Outbreak Analytics, Office of Human Resources, Global Health Center, Office of Acquisition Services and Office of Communications. HHS spokesperson Andrew Nixon did not immediately respond to a request for comment. He told Fox News, which first reported the news: 'The Trump Administration is committed to protecting essential services — whether it's supporting coal miners and firefighters through [the National Institute for Occupational Safety and Health], safeguarding public health through lead prevention, or researching and tracking the most prevalent communicable diseases.' — Key context: In April, roughly 2,400 CDC employees received termination notices amid a massive reorganization of the Department of Health and Human Services. But the agency has periodically rehired staff over the past few months.

What to know about the new ‘Nimbus' COVID variant
What to know about the new ‘Nimbus' COVID variant

The Hill

time35 minutes ago

  • The Hill

What to know about the new ‘Nimbus' COVID variant

The World Health Organization is keeping an eye on a new COVID-19 variant called NB.1.8.1, or 'Nimbus,' that has spread across Europe, the Americas and the Western Pacific. Nimbus is a descendant of the Omicron variant of the virus and was first identified in late January. Its spike mutations appear to make it more transmissible than other COVID variants, according to the WHO. Spike mutations refer to changes in spike proteins, which sit on the surface of the virus and help it enter healthy cells. While it is spreading in the U.S. and Canada, along with 20 other countries, it does not appear to be driving an increase in sickness or hospitalization. In April, NB.1.8.1 sequences made up 10.7 percent of all submitted sequences from confirmed COVID infections, up from 2.5 percent a month earlier, according to a risk evaluation released by the WHO. The WHO last month deemed NB.1.8.1 a variant 'under monitoring.' Here's what to know about the variant. Most cases of COVID-19 in the U.S. still stem from the LP.8.1 strain, another Omicron descendant. But it looks like NB.1.8.1 might soon replace it as the more common strain, according to data from the Centers for Disease Control and Prevention (CDC). The CDC estimates that 37 percent of COVID-19 cases in the U.S. stem from the NB.1.8.1 variant while 38 percent are a result from an infection of the LP.8.1 strain of the disease. At the end of May, the agency estimated that the NB.1.8.1 variant caused about 15 percent of all COVID cases. But the agency notes on its website that due to low numbers of virus sequences being reported, precision in the most recent reporting period is low. The NB.1.8.1 variant has been found in at least 13 states, according to Today, which cited data from the Global Initiative on Sharing All Influenza Data (GISAID) database. Those states are: California, New York, New Jersey, Maryland, Arizona, Illinois, Hawaii, Massachusetts, Ohio, Rhode Island, Vermont, Virginia and Washington. The available data on 'Nimbus' suggests that it poses a low global threat and that existing COVID-19 vaccines provide adequate protection against severe illness and hospitalization, according to the WHO. 'Currently approved COVID-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease,' reads the WHO's risk evaluation. 'Despite a concurrent increase in cases and hospitalizations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation.' Lionel Gesh, an international consultant at the WHO, told The Hill that many new cases in Canada are likely linked to the NB.1.8.1 variant, but that there has not been any major changes in the country in terms of cases, hospitalizations, ICU admissions or deaths linked to COVID-19. Symptoms of NB.1.8.1 seem to be similar to those associated with other Omicron variants, according to Gresh. Some common COVID-19 symptoms include cough, fever, fatigue, muscle aches, congestion, headache, nausea, vomiting, and a new loss of smell or taste, according to the CDC. 'We should be as concerned about [NB.1.8.1] as we are concerned for COVID in general,' Gesh said. 'Not more, not less.' Some recent COVID-19 patients have reported experiencing something called 'razor blade throat,' according to Salon. But it is unclear if that symptom is connected to one of the COVID variants or another respiratory illness circulating, Ryan Gregory, an evolutionary and genome biologist at the University of Guelph in Canada, told the outlet.

Unpacking RFK's lengthy social media post after firing vaccine committee members
Unpacking RFK's lengthy social media post after firing vaccine committee members

USA Today

time38 minutes ago

  • USA Today

Unpacking RFK's lengthy social media post after firing vaccine committee members

Unpacking RFK's lengthy social media post after firing vaccine committee members Show Caption Hide Caption RFK Jr. expels entire CDC vaccine advisory committee Health Secretary Robert Kennedy Jr. removed a 17-member panel at the Centers for Disease Control and Prevention that issues recommendations on vaccines. unbranded - Newsworthy A day after abruptly firing the entire committee that advises the federal government on vaccine safety, Health and Human Services Secretary Robert F. Kennedy Jr. said he would reconstitute it with 'highly credentialed physicians and scientists' amid backlash from his detractors about the terminations. In a long post on X on June 10, Kennedy criticized the process by which the Advisory Committee for Immunization Practices recommends new vaccines, implying that "adequate safety trials" were not being conducted before recommending new vaccines to children, a notion that was strongly disputed by vaccine experts. Kennedy, who has a long record of promoting anti-vaccine views, also said the new Advisory Committee for Immunization Practices will have no 'ideological anti-vaxxers' but that the committee will apply 'evidence-based decision-making with objectivity and common sense.' 'The most outrageous example of ACIP's malevolent malpractice has been its stubborn unwillingness to demand adequate safety trials before recommending new vaccines for our children,' he wrote. Kennedy said a compliant American child receives more shots now from conception to 18 years of age compared to 1986, none of which required placebo-controlled trials. That was the year when the Vaccine Injury Compensation Program was set up, protecting vaccine makers from liability and establishing a federal program to compensate individuals injured by certain vaccines. 'This means that no one can scientifically ascertain whether these products are averting more problems than they are causing,' he wrote. A placebo-controlled study is a type of clinical trial where one group of participants receives an active treatment, while another group receives an inactive substance, helping researchers to determine whether the active treatment is truly effective. But conducting placebo-controlled studies on vaccines that are improvements on existing vaccines presents ethical and practical challenges, say vaccine experts. 'If a vaccine for a serious disease (e.g., measles, polio) already exists and is proven effective, giving participants a placebo instead of the vaccine could expose them to preventable harm or death,' wrote Dr. Jerome Adams, the former U.S. Surgeon General under President Trump's first term, in a June 9 post on X. How do vaccines work? Medical experts explain. New vaccines always undergo a placebo-controlled study, said Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia and a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee. But Kennedy's definition of placebo is different from FDA's, said Offit. Kennedy has sought to narrowly define placebos as salt water, said Offit, while the FDA defines it as an 'inactive substance.' 'A placebo may contain sodium sulfate or potassium sulfate or may contain sucrose, or it may contain an emulsifier – those are all generally regarded as safe,' said Offit. 'He doesn't regard them as safe.' HHS did not respond to USA TODAY seeking a comment on how Kennedy's definition differs from that of the FDA. Offit said Kennedy is a lawyer who has spent years suing pharmaceutical companies, and 'his job is to scare people about vaccines ultimately, so he can bring them back to court and sue companies,' he said. Meanwhile, in his announcement of the removal of the 17 members of the ACIP committee Kennedy said the purpose was to insulate the committee from 'conflicts of interest.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store